About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.